Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers

Vaccine

Volumn 16, Issue 8, 1998, Pages 810-817

  McBride, B W ^a   Mogg, A ^a   Telfer, J L ^a   Lever, M S ^a   Miller, J ^b   Turnbull, P C B ^a   Baillie, L ^b  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

Anthrax; Immunological markers; Vaccine efficacy

Indexed keywords

ADJUVANT; ALUMINUM HYDROXIDE; ANTIGEN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; RECOMBINANT PROTEIN; VACCINE;

ANIMAL MODEL; ANIMAL TISSUE; ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GUINEA PIG; IMMUNOLOGICAL PARAMETERS; INTRAMUSCULAR DRUG ADMINISTRATION; LUNG LAVAGE; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; AEROSOLS; ALUMINUM HYDROXIDE; ANIMALS; ANTHRAX; ANTIBODIES, BACTERIAL; BACILLUS ANTHRACIS; CELL WALL SKELETON; CORD FACTORS; EVALUATION STUDIES; FEMALE; GUINEA PIGS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; LIPID A; LUNG; LYMPHOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MALE; SPORES, BACTERIAL;

EID: 0032078170     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00268-5     Document Type: Article

References (27)

1. 1 Keppie, J., Harris-Smith, P.W. and Smith, H. The chemical basis of the virulence of Bacillus anthracis. IX Its aggressins and their mode of action. British Journal of Experimental Pathology 1963, 44, 446-453.
2. 2 Zwartouw, H.T. and Smith, H. Polyglutamic acid from Bacillus anthracis grown in vivo: structure and aggressin activity. Biochemistry Journal 1956, 63, 437-442.
3. 3 Mikesell, P., Ivins, B.E., Ristroph, J.D. and Drier, T.M. Evidence for plasmid-mediated toxin production in Bacillus anthracis. Infection and Immunity 1983, 39, 371-376.
4. 4 Molloy, S.S., Bresnahan, P.A., Leppla, S.H., Kumpel, K.R. and Thomas, G. Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. Journal of Biological Chemistry 1992, 267, 16396-16402.
5. 5 Milne, J.C., Furlong, D., Hanna, P.C., Wall, J.S. and Collier, R.J. Anthrax protective antigen forms oligomers during intoxication of mammalian cells. Journal of Biological Chemistry 1994, 269, 20607-20612.
6. 6 Hanna, P.C., Acosta, D. and Collier, J.R. On the role of macrophages in anthrax. Proceedings of the National Academy of Science USA 1993. 90, 10198-10201.
7. 7 Belton, F.C. and Strange, R.E. Studies on a protective antigen produced in vitro from Bacillus anthracis: medium and methods of production. British Journal of Experimental Pathology 1954, 35, 144-152.
8. 8 Henderson, D.W., Peacock, S. and Belton, F.C. Observations on the prophylaxis of experimental pulmonary anthrax in the monkey. Journal of Hygiene 1956, 54, 28-36.
9. 9 Broster, M.G. and Hibbs, S.E. Protective efficacy of anthrax vaccines against aerosol challenge. Salisbury Medical Bulletin 1990, 68(Suppl.), 91-92.
10. 10 Auerbach, S. and Wright, G.G. Studies on immunity in anthrax. VI. Immunizing activity of protective antigen against various strains of Bacillus anthracis. Journal of Immunology 1955, 75, 129-133.
11. 11 Ward, M.K., McGann, V.G. and Hogge, A.L Jr.Jr. et al. Studies on anthrax infections in immunized guinea pigs. Journal of Infectious Diseases 1965, 115, 59-67.
12. 12 Turnbull, P.C.B., Leppla, S.H., Broster, M.G., Quinn, C.P. and Melling, J. Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity. Medizin Microbiologie und Immunologie Berlin 1988, 177(5), 293-303.
13. 13 Ivins, B.E., Welkos, S.L., Little, S.F., Crumrine, M.H. and Nelson, G.O. Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants. Infection and Immunity 1992, 60, 662-668.
14. 14 Ivins, B., Fellows, P. and Pitt, L. et al. Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs. Vaccine 1995, 13, 1779-1784.
15. 15 Turnbull, P.C.B., Quinn, C.P., Hewson, R., Stockbridge, M.C. and Melling, J. Protection conferred by microbially-supplemented UK and purified PA vaccines. Proceedings of the International Workshop on Anthrax. Salisbury Medical Bulletin 1990, 68(Suppl.), 89-91.
16. 16 Jones, M.N., Beedham, R.J., Turnbull, P.C.B., Fitzgeorge, R.B. and Manchee, R.J. Efficacy of the UK human anthrax vaccine in guinea pigs against aerosolised spores of Bacillus anthracis. Salisbury Medical Bulletin 1995. 87(Suppl.), 123-124.
17. 17 Ivins, B.E. and Welkos, S.L. Cloning and expression of the Bacillus anthracis protective antigen gene in Bacillus subtilis. Infection and Immunity 1986, 54(2), 537-542.
18. 18 Wu, X.C., Lee, W., Tran, L. and Wong, S.L. Engineering a Bacillus subtilis expression-secretion system with a strain deficient in six extracellular proteases. Journal of Bacteriology 1991, 173, 4952-4958.
19. 19 Baillie, L.W., Johnson, M. and Manchee, R.J. Evaluation of Bacillus subtilis strain IS53 for the production of Bacillus anthracis protective antigen. Letters in Applied Microbiology 1994, 19(4), 225-227.
20. 20 Jones, M.N., Beedham, R.J., Turnbull, P.C.B. and Manchee, R.J. Antibiotic prophylaxis for inhalation anthrax. Salisbury Medical Bulletin 1995, 87(Suppl.), 127-128.
21. 21 Fitzgeorge, R.B. The effect of antibiotics on the growth of Legionella pneumophila in guinea pig alveolar phagocytes infected in vivo by an aerosol. Journal of Infection 1985, 10, 189-193.
22. 22 Henderson, D.W. An apparatus for the study of airborne infection. Journal of Hygiene 1952, 50, 53-68.
23. 23 Allison, A.C. and Byars, N.E. An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity. Journal of Immunological Methods 1986, 95, 157-168.
24. 24 White, R.G. The adjuvant effect of microbial products on the immune response. Annual Reviews in Microbiology 1976, 30, 579.
25. 25 Webster, R.O. and Lawrence, D.A. Antigenic modulation of the cytophilic binding of guinea pig IgG and IgM antibodies to homologous macrophages. Immunology 1979, 36, 659-670.
26. 26 Ohlander, C., Larsson, A. and Perlmann, P. Specificity of Fc-receptors on lymphocytes and monocytes for guinea pig IgG1 and IgG2: phagocytosis of erythrocytes. Scandinavian Journal of Immunology 1978, 7, 285-296.
27. 27 Limb, G.A., Brown, K.A., Wolstencroft, R.A., Ellis, B.A. and Dumonde, D.C. Modulation of Fc and C3b receptor expression on guinea pig macrophages by lymphokines. Clinical Experimental Immunology 1988, 74, 171-176.